01 5Synergy Health AST, LLC
01 5pasireotide
01 5U.S.A
NDC Package Code : 71161-130
Start Marketing Date : 2018-06-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : INJECTION, POWDER, FOR SUSPENSION (15mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 71161-128
Start Marketing Date : 2014-12-15
End Marketing Date : 2024-12-31
Dosage Form (Strength) : INJECTION, POWDER, FOR SUSPENSION (20mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 71161-126
Start Marketing Date : 2014-12-15
End Marketing Date : 2024-12-31
Dosage Form (Strength) : INJECTION, POWDER, FOR SUSPENSION (30mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 71161-129
Start Marketing Date : 2014-12-15
End Marketing Date : 2024-12-31
Dosage Form (Strength) : INJECTION, POWDER, FOR SUSPENSION (10mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 71161-127
Start Marketing Date : 2018-07-12
End Marketing Date : 2024-12-31
Dosage Form (Strength) : INJECTION, POWDER, FOR SUSPENSION (5mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
We have 1 companies offering Pasireotide
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
